• Users Online: 228
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2018  |  Volume : 7  |  Issue : 1  |  Page : 1-5

The effects of home-based nursing care on metabolic control among patients with type ii diabetes mellitus: A randomized clinical trial


1 Chronic Diseases (Home Care) Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Community Health Nursing, Hamadan University of Medical Sciences, Hamadan, Iran
3 Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

Correspondence Address:
Afsar Omidi
Department of Community Health Nursing, Chronic Diseases (Home Care) Research Center, Hamadan University of Medical Sciences, Hamadan
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/nms.nms_61_17

Get Permissions

Background: Diabetes mellitus (DM) management is challenging, particularly for people in developing countries. Objective: This study aimed to examine the effects of a home-based nursing care (HBNC) program on metabolic control among patients with type II DM. Methods: This single-blind randomized controlled trial was conducted in Hamadan, Iran, in 2014. Sixty patients with type II DM were consecutively recruited from a public diabetes care clinic in Hamadan, Iran, and randomly allocated to an experimental and a control group. Patients in the control group received usual discharge services, while their counterparts in the experimental group received HBNC services in addition to usual discharge services. The levels of fasting blood glucose, hemoglobin A1C, total cholesterol, triglycerides, high- and low-density lipoprotein cholesterols, and systolic and diastolic blood pressures were measured before and 3 months after the intervention. Data analysis was performed through the Chi-square, the paired-sample and the independent-sample t-tests. Results: HBNC program significantly decreased the levels of fasting blood glucose (from 206.60 ± 84.93 to 141.40 ± 48.75; P < 0.001), hemoglobin A1C(from 9.25 ± 2.19 to 7.55 ± 1.54; P < 0.001), and triglycerides (from 165.80 ± 78.96 to 126.63 ± 45.21; P < 0.01). However, it had no significant effects on total cholesterol, high- and low-density lipoproteins, and systolic and diastolic blood pressures (P > 0.05). Conclusion: HBNC is an effective strategy for managing type II DM and decreasing the risk of its complications.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed606    
    Printed94    
    Emailed0    
    PDF Downloaded152    
    Comments [Add]    

Recommend this journal